Literature DB >> 28821933

Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations.

Mingshan Niu1,2, Yangling Shen1, Jialei Qi1, Xuejiao Liu3, Wei Sang2, Qingyun Wu1, Jiang Cao2, Wei Chen2, Yao Yao4, Kailin Xu5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28821933     DOI： 10.1007/s00277-017-3093-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

1.  Acid Water-ground Nano-realgar Is Superior to Crude Realgar in Promoting Apoptosis of MCF-7 Breast Cancer Cells.

Authors:  Juan Xi; Jia-Hui Fang; Xiao-Mei Xiong; Chun Gui; Yu-Xue Wang; Xiu-Qiao Zhang
Journal:  Curr Med Sci       Date:  2022-07-05

2.  High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia.

Authors:  Mingshan Niu; Yuan Feng; Ninghan Zhang; Tingting Shao; Huihui Zhang; Rong Wang; Yao Yao; Ruosi Yao; Qingyun Wu; Jiang Cao; Xuejiao Liu; Yubo Liu; Kailin Xu
Journal:  Cancer Cell Int       Date:  2019-05-07       Impact factor: 5.722

3.  MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia.

Authors:  Mingshan Niu; Ninghan Zhang; Rong Wang; Tingting Shao; Yuan Feng; Yangling Shen; Xuejiao Liu; Kai Zhao; Shengyun Zhu; Linyan Xu; Yao Yao; Kailin Xu
Journal:  Front Oncol       Date:  2019-10-11       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.